The OPTASE range is a safe, tested and expert recommended 3-step regime to help tackle the cause and symptoms of eye conditions
The acquisition will strengthen the overall company’s position as leading global CRO services partner
Emcure will play a crucial role in ensuring the availability of high-quality, low-cost versions of lenacapavir in 120 countries
Grant funding from the Bill & Melinda Gates Foundation will support the rapid and efficient design and synthesis of novel small molecules
Gilead Sciences first launched Lenacapavir under the brand name Sunlenca in the United States and Europe markets in the year 2022
Agreement enables access of EU-approved treatment for myotonia symptoms in non-dystrophic myotonic disorders to patients from Argentina and Colombia
The primary objective was to evaluate safety and tolerability of Ropanicant in patients with MDD
A new initiative to contribute to enhancing drug discovery capabilities in the field of gene and cell therapy in Japan
The partnership aims to revolutionize Artificial Intelligence in health research with innovative data platform
Vonoprazan is used in the treatment of disorders related to Gastroesophageal Reflux Disease (GERD)
Subscribe To Our Newsletter & Stay Updated
